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Objective. To describe the diverse patterns observed with the use of autoﬂuorescence fundus photography (FAF) in patients with
Birdshot chorioretinopathy (BSCR). Methods. A chart review of patients with BSCR seen at the Massachusetts Eye Research and
Surgery Institution, who had autoﬂuorescence fundus photography. The data obtained included age, gender, presence of the HLA-
A29 haplotype, and current treatment. Results. Eighteen eyes with HLA-A29 associated BSCR were included. Four eyes presented
with active inﬂammation. Correspondence of the lesions noted in the colour fundus photograph was observed in 3 eyes which
were more easily identiﬁed with the FAF. Fifteen eyes had fundus lesions more numerous and evident in the FAF than in the colour
fundus photograph. Conclusion. Because FAF testing provides valuable insight into the metabolic state of the PR/RPE-complex, it
mayserveasausefulnoninvasiveassessmenttoolinpatientswithposterioruveitisinwhichtheouterretina-RPE-choriocapillaries-
complex is involved.
Copyright © 2009 GianPaolo Giuliari et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Birdshot chorioretinopathy (BSCR) is an uncommon cause
of chronic posterior uveitis, most frequently aﬀecting Cau-
casian women in the ﬁfth and sixth decades of life [1, 2]. The
mostcommonclinicalsignsarevitritisandmultiplebilateral,
hypopigmented inﬂammatory lesions in the post-equatorial
fundus [3–5].
The aetiology of BSCR remains unclear, although a
relationship exists with the human leukocyte antigen (HLA)
-A29; therefore, an autoimmune mechanism has been pro-
posed [5–7].
Due to the variety of clinical manifestations observed
in BSCR, the diagnosis may be elusive, especially early in
the course of the disease, prior to the evolution of the
characteristic hypopigmented spots in the fundus [8, 9].
Additionally, the diﬀuse pigmentary loss noted through
time in the typical choroidoretinal lesions of BSCR is not
a reliable marker of disease activity. Furthermore, some
studies suggest that the retinal vascular leakage observed by
ﬂuorescein angiography (FA) may not be suﬃcient to decide
on treatment [10].
Diﬀerent techniques and ancillary testing are crucial in
patients with BSCR, not only for diagnostic purposes but to
guide adequate follow up and treatment monitoring as well.
An extensive clinical history and ophthalmic examination
accompanied by fundus photography along with FA and
electroretinography, remain invaluable to the management
of these patients.
Fundus autoﬂuorescence photography (FAF) is a rela-
tively new retinal assessment technique which capitalizes on
the presence of lipofuscin, an important substance found
in the retinal pigment epithelial (RPE) cells, allowing us to
obtain unique information about the structure and function
of the RPE [11]. FAF may better assess the presence of the
typical inﬂammatory lesion observed in fundus of patients
with BSCR, and facilitate its visualization in patients with
blond fundus.2 Journal of Ophthalmology
Table 1: Demographic characteristics.
Patients Eye Age Gender Diagnosis∗ HLA A29 Treatment VA ERG∗∗ OCT∗∗∗
1 OD 50 Female 2001 Positive Daclizumab 20/20 38 241
OS 20/30 30 383
2 OD 48 Male 1997 Positive MMF+CSA 20/50 35 562
OS 20/20 30.5 241
3 OD 58 Female 2008 Positive MMF+CSA 20/30 34.5
OS 20/25 31.5
4 OD 59 Male 1998 Positive MMF+CSA 20/20 35.7
OS 20/25 31.9
5 OD 58 Female 2004 Positive MMF+CSA 20/25 36.8 165
OS 20/40 44.5 312
6 OD 69 Female 2007 Positive IVIG 20/25 32.7
OS 20/30 31.8
7 OD 53 Female 2006 Positive MMF+CSA 20/20 29
OS 20/20 27.8
8 OD 56 Female 2005 Positive Daclizumab 20/20 31.5 213
OS 20/20 30.5 217
9 OD 49 Female 2005 Positive Adalimumab 20/20 27.5
OS Prednisone 20/20 26
∗Year in which the diagnosis was made; ∗∗Implicit times (ms); ∗∗∗Central macular thickness (microns).
VA: Best corrected visual acuity; ERG: electroretinogram; OCT: optical coherence tomography; MMF: mycophenolate mofetil; CSA: cyclosporine; IvIg:
intravenous immunoglobulin.
2. Methods
This retrospective case series study was approved by the
Institutional Review Board of the Massachusetts Eye and Ear
Inﬁrmary, and adheres to the tenets of the Declaration of
Helsinki. All patients with BSCR seen at the Massachusetts
Eye Research and Surgery Institution (MERSI), from July
2008 to October 2008, who underwent FAF imaging, were
included in the analysis. Those patients in whom macular
oedema was clinically suspected, the central macular thick-
ness (CMT) was recorded by time domain optical coherence
tomography (OCT-Stratus III, Carl Zeiss, Meditec, Dublin,
CA).
Data were obtained through review of the electronic
medical records of each patient (NextGen, Horsham, PA)
and entered into Excel (Microsoft Corporation, Redmond,
Washington) data entry worksheets. General data included
age,gender,presenceoftheHLA-A29haplotype,andcurrent
therapeutic regimen. To evaluate the clinical status of the
disease, a complete ophthalmic examination was performed
with the use of slit lamp biomicroscopy, noncontact fundus
lens,andindirectophthalmoscopy. Theocularinﬂammatory
status was judged according to the Standardization of Uveitis
Nomenclature (SUN) Working Group criteria [12], as well
as ﬁndings on the FA. Active inﬂammation was deﬁned as
≥1+ anterior chamber cell/ﬂare and/or ≥1+ vitreous haze.
FA signs considered indications of active disease included
hyperﬂuorescence of the optic disc, leakage of dye from
capillaries and venules during the late phase, and delayed
arterial ﬁlling time.
FAF was performed using a fundus camera (Topcon
Medical Systems, Paramus, NJ—Spectrotech) with an exci-
tation ﬁlter peak at 560nm (bandwidth, 535–585nm) and a
barrier ﬁlter centered at 655nm (bandwidth, 605–705nm).
3. Results
Eighteen eyes of 9 patients met the inclusion criteria and
were included in the analysis. All patients had the HLA-A29
haplotype. The mean age was 55.5 years (range 48–69 years).
Two patients (22%) were males. The median visual acuity
was 20/25 (range 20/20–20/50).
The most common treatment regimen employed was
mycophenolate mofetil, and cyclosporine alone or combined
in ﬁve (56%) patients. Daclizumab was employed in two
patients; adalimumab and intravenous immunoglobulin
were employed in one patient each. One patient was taking
oral corticosteroids (Table 1).
Four (22%) eyes presented with active inﬂammation
characterized by optic nerve leaking and/or retinal vasculitis
assessed by FA. Three (17%) eyes presented with macular
oedema conﬁrmed both by FA and OCT. None of the
eyes with macular oedema showed macular hypoautoﬂuo-
rescence. Full correspondence of the lesions noted in the
colour fundus photograph was observed in 3 (17%) eyes
of 2 patients; however, they were more easily identiﬁed
with the FAF. In 15 eyes (83%), fundus lesions were more
numerous and more easily identiﬁed in the FAF than in the
colourfundusphotograph.ThesefundihadthetypicalBSCR
lesions, peripapillary chorioretinal atrophy characterized asJournal of Ophthalmology 3
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Figure 1: Images from the left eye of a 58-year-old woman with birdshot chorioretinopathy (patient 3). (a) Fundus colour photograph
shows poorly pigmented fundus with scatter BSCR around the optic nerve, superior arcade, and inferior to the fovea. (b) Autoﬂuorescence
photograph shows scattered areas of RPE atrophy as hypoautoﬂuorescent spots correspondent to the BSCR noted in the colour photograph.
(a) (b)
Figure 2: Images from the left eye of a 58-year-old woman with birdshot chorioretinopathy (patient 5). (a) Fundus colour photograph
shows poorly pigmented fundus with scatter BSCR lesions nasal to the optic nerve. (b) Autoﬂuorescence photograph shows scattered areas
of RPE atrophy as hypoautoﬂuorescent spots and as a linear pattern along the retinal vessels.
a circumferential hypoautoﬂuorescence around the optic
nerve, and in 3 (17%) eyes a linear hypoautoﬂuorescence
pattern along the retinal vessels was noted (Figures 1 and 2).
4. Discussion
Despite recent advances in diagnostic imaging, the diagnosis
of BSCR remains a challenge. OCT is extremely valuable
in the quantiﬁcation and monitoring of macular oedema,
the most common complication resulting in vision loss in
BSCR [5, 6, 10, 11, 13]. Despite the limitations of FA,
it remains an important tool to assess the status of the
retinal vasculature [10]. These techniques are augmented by
full ﬁeld electroretinogram (ERG) in which an important
correlation between the progression of the disease has been
found with the ﬂicker implicit time and bright scotopic
B-wave amplitude [14–16]. Indocyanine green angiography
andvisualﬁeldtesting(especiallywithSITA-SWAPprotocol)
are valuable tools in the care and longitudinal monitoring of
these patients with BSCR [17, 18].
More recently, FAF, a relatively new technique, has been
employed to evaluate the characteristics of the chorioretinal
lesions in BSCR [19]. This new technology was ﬁrst used in
the care of patients with dry age related macular degener-
ation, and more recently in patients with diﬀerent types of
posterior uveitis including multifocal choroiditis and BSCR
[20, 21].
We noted a wide spectrum of FAF patterns in our
cohort. The typical BSCR fundi lesions did not necessarily
correspond to the areas of RPE atrophy shown with the
FAF. In 3 eyes, full correspondence of the BSCR lesions was
observed. The remaining eyes (15 eyes) showed more areas
of RPE atrophy in the FAF than in the colour photograph.
Lesions were signiﬁcantly easier to identify in the FAF than
in the colour photograph, especially in those eyes with light
fundus pigmentation in which the visualization of BSCR
lesions can be challenging. Figure 3 shows the right eye of a
69-year-old female with a well-conﬁrmed BSCR diagnosis of
almost 2 years, with HLA-A29 haplotype. At the moment of
the FAF, she presented with a visual acuity of 20/25 and was
in treatment with intravenous immunoglobulin. Note in the
colour photograph (Figure 3(a)) the hypopigmented lesions
nasal to the optic nerve and around the arcades; however due
tothepoorfunduspigmentation,theselesionsarediﬃcultto
visualize. Note the striking diﬀerence with the FAF in which
areas of RPE atrophy are signiﬁcantly more numerous and
clear than in the colour photograph. A perivascular linear4 Journal of Ophthalmology
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Figure 3: Images from the right eye of a 69-year-old woman with birdshot chorioretinopathy (patient 6). (a) Fundus photograph shows
a poorly pigmented fundus with scattered lesions nasally and superior of the optic nerve (black arrow). (b) Autoﬂuorescence photograph
demonstrates circumferential hypoautoﬂuorescence around the optic nerve, scattered multiple multifocal hypoautoﬂuorescent spots, and a
linear hypoautoﬂuorescence pattern along the retinal vessels (white arrows).
FAF pattern shown in Figures 2 and 3 was also noted. This
ﬁndingwaspreviouslydescribedbyKoizumietal.andledhis
group to postulate a possible role of inﬂammation induced
damage of the RPE [19].
TheoriginofBSCRlesionsiscontroversial.Someauthors
support the idea that birdshot is a chorioretinopathy, while
others believe that it is a retinochoroidopathy [22]. This lack
of correspondence between the colour fundus photograph
and the FAF, as suggested by other authors, may indeed
be explained by two separate mechanisms of damage of
the choroid and the RPE, which may vary in each patient
[19].
FAF testing provides valuable insight into the metabolic
state of the PR/RPE complex; we ﬁnd it useful as a noninva-
sive diagnostic tool in patients with posterior uveitis, when
the outer retina-RPE choriocapillaries complex is involved.
Limitations for this study include the small sample size and
the inherent bias of its retrospective nature.
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